This inventor holds 8 USPTO granted patents and 9 published patent applications. Top assignees: Johns Hopkins University, Other. Active years: 2020-2025.
Location History:
- Canoga Park, CA (US) (2020)
- Tarzana, CA (US) (2021 - 2022)
Company Filing History:

Years Active: 2020-2025
Title: Innovations and Contributions of Inventor Lian Liu
Introduction
Lian Liu is a notable inventor based in Tarzana, CA (US), recognized for his significant contributions to the field of medical technology. With a total of 8 patents, Liu has focused on developing innovative solutions for health-related issues, particularly in the areas of gastrointestinal disorders and prenatal testing.
Latest Patents
Lian Liu's latest patents include groundbreaking methods for treating irritable bowel syndrome (IBS) using molybdenum. This patent describes methods for treating or preventing IBS in subjects by administering molybdenum or a salt thereof. The research indicates that molybdenum has shown efficacy in treating or preventing IBS compared to reference subjects not administered this agent. Another significant patent involves methods and systems for cell-based non-invasive prenatal testing. This innovation provides a system for isolating fetal cells from a maternal blood supply, facilitating non-invasive prenatal testing. The system includes a substrate coated with a cell-capturing surface, featuring an array of pillar-like structures designed to enhance cell capture.
Career Highlights
Throughout his career, Lian Liu has made substantial contributions to medical research and technology. His work has been instrumental in advancing methods that improve patient care and outcomes in both gastrointestinal health and prenatal diagnostics.
Collaborations
Lian Liu has collaborated with esteemed colleagues, including Shuang Hou and Chun-Hao Luo, who have contributed to his research endeavors and innovations.
Conclusion
Lian Liu's innovative work and patents reflect his commitment to improving healthcare through technology. His contributions have the potential to significantly impact the fields of gastrointestinal treatment and prenatal testing.